| The clinical progress of mRNA vaccines and immunotherapies AJ Barbier, AY Jiang, P Zhang, R Wooster, DG Anderson Nature biotechnology 40 (6), 840-854, 2022 | 315 | 2022 |
| Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing B Li, RS Manan, SQ Liang, A Gordon, A Jiang, A Varley, G Gao, R Langer, ... Nature biotechnology 41 (10), 1410-1415, 2023 | 74 | 2023 |
| Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA B Li, AY Jiang, I Raji, C Atyeo, TM Raimondo, AGR Gordon, LH Rhym, ... Nature Biomedical Engineering, 1-18, 2023 | 15 | 2023 |
| Emerging immunomodulatory strategies for cell therapeutics CYX Chua, AY Jiang, T Eufrásio-da-Silva, A Dolatshahi-Pirouz, R Langer, ... Trends in Biotechnology 41 (3), 358-373, 2023 | 13 | 2023 |
| A survival selection strategy for engineering synthetic binding proteins that specifically recognize post-translationally phosphorylated proteins B Meksiriporn, MB Ludwicki, EA Stephens, A Jiang, HC Lee, ... Nature communications 10 (1), 1830, 2019 | 9 | 2019 |
| Combinatorial development of nebulized mRNA delivery formulations for the lungs AY Jiang, J Witten, IO Raji, F Eweje, C MacIsaac, S Meng, FA Oladimeji, ... Nature nanotechnology 19 (3), 364-375, 2024 | 7 | 2024 |
| Compositions and Methods for Adjuvanted Vaccines B Li, A Jiang, RS Langer, DG Anderson US Patent App. 18/190,068, 2023 | | 2023 |
| Ionizable lipids and compositions and uses thereof DG Anderson, LH Rhym, A Jiang, J Witten, I Raji US Patent App. 18/080,299, 2023 | | 2023 |
| Optimized Lipid Nanoparticles and Delivery Conditions for State-of-the-Art Nebulized mRNA Delivery to the Lungs A Jiang, J Witten, I Raji, S Eweje, C MacIsaac, F Oladimeji, R Langer, ... 2022 AIChE Annual Meeting, 2022 | | 2022 |
| Engineering Dually Adjuvanted Sars-CoV2 mRNA Vaccines A Jiang, B Li, I Raji, C Atyeo, TM Raimondo, A Gordon, L Rhym, G Alter, ... 2022 AIChE Annual Meeting, 2022 | | 2022 |
